Figure 7.Prediction of the sensitivity of high risk patients to chemotherapy drugs and immunotherapy. (A) Cisplatin. (B) Doxorubicin. (C) Methotrexate. (D) Gemcitabine. (E) Vinblastine. (F) Immune checkpoint receptor: PD1-R, PD1-noR, CTLA4-R, ctal4-noR.
